ArticleExperimental & molecular medicine2022

Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stress.

Debra Dorotea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.